Evidence map›Paper›PMID 31058086›Full record

ArticleFrontiers in oncology2019

Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling.

Sabah Akhtar, Iman W Achkar, Kodappully S Siveen, Shilpa Kuttikrishnan, Kirti S Prabhu, Abdul Q Khan, Eiman I Ahmed, Fairooz Sahir, Jayakumar Jerobin, Afsheen Raza and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. TMJ-105, an extract ofHeliyon · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Sabah AkhtarTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Iman W AchkarTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Kodappully S SiveenTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Shilpa KuttikrishnanTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Kirti S PrabhuTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Abdul Q KhanTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Eiman I AhmedTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Fairooz SahirTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Jayakumar JerobinTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Afsheen RazaTranslational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Maysaloun MerhiTranslational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Hesham M ElsabahNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Ruba TahaNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Halima El OmriNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Hatem ZayedDepartment of Biomedical Sciences, College of Health Sciences, Qatar University, Doha, Qatar.
Said DermimeTranslational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Martin SteinhoffTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Shahab UddinTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QANational Center for Cancer Care and Research · QACornell University · USQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sanguinarine (SNG), a benzophenanthridine alkaloid, has displayed various anticancer abilities in several vivo and

Indexed as

apoptosiscaspaseshematological malignancymultiple myelomasanguinarineSTAT3

Identifiers

PMID31058086
PMCPMC6478801
OpenAlexW2936547124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.